Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: The losartan intervention for endpoint reduction in hypertension (LIFE) study

Circulation

Volumn 113, Issue 1, 2006, Pages 67-73

  Okin, Peter M ^a   Devereux, Richard B ^a   Nieminen, Markku S ^b   Jern, Sverker ^c   Oikarinen, Lasse ^b   Viitasalo, Matti ^b   Toivonen, Lauri ^b   Kjeldsen, Sverre E ^d,e   Dahlöf, Björn ^c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Blood pressure; Electrocardiography; Heart failure; Hypertension; Hypertrophy

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; LOSARTAN;

ADULT; AGED; ALBUMINURIA; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; ELECTRIC POTENTIAL; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SMOKING; SOKOLOW LYON VOLTAGE; ST SEGMENT DEPRESSION; STATISTICAL SIGNIFICANCE; STRAIN IDENTIFICATION; STROKE; SYSTOLIC BLOOD PRESSURE; T WAVE INVERSION; BLOOD PRESSURE; ECHOGRAPHY; INCIDENCE; METHODOLOGY; MIDDLE AGED; MORTALITY; PREDICTION AND FORECASTING; PROGNOSIS; PROSPECTIVE STUDY; STRESS ECHOCARDIOGRAPHY;

AGED; AGED, 80 AND OVER; BLOOD PRESSURE; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY, STRESS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 33644853347     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.569491     Document Type: Article

References (32)

1. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949;37:161-186.
2. Romhilt DW, Estes EH. A point-score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J. 1968;75:752-759.
3. Reichek N, Devereux RB. Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings. Circulation. 1981;63:1391-1398.
4. Devereux RB, Reichek N Repolarization abnormalities of left ventricular hypertrophy: clinical, echocardiographic and hemodynamic correlates. J Electrocardiol. 1982;15:47-54.
5. Levy D, Labib SB, Andersen KM, Christiansen JC, Kannel WB, Castelli WP. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation. 1990;81:815-820.
6. Schillaci G, Verdecchia P, Borgioni C, Ciucci A, Guerrieri M, Zampi I, Battistelli M, Bartoccini C, Porecellata C. Improved electrocardiographic diagnosis of echocardiographic left ventricular hypertrophy. Am J Cardiol. 1994;74:714-719.
7. Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Julius S, Dahlöf B. Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. J Am Coll Cardiol. 2001;38:514-520.
8. Okin PM, Devereux RB, Fabsitz RR, Lee ET, Galloway JM, Howard BV. Quantitative assessment of electrocardiographic left ventricular strain predicts increased left ventricular mass: the Strong Heart Study. J Am Coll Cardiol. 2002;40:1395-1400.
9. Sokolow M, Perloff D. The prognosis of essential hypertension treated conservatively. Circulation. 1961;33:697-713.
10. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, Porcellati C. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy. J Am Coll Cardiol. 1998;31:383-390.
11. Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Julius S, Snapinn S, Dahlöf B. Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients. Hypertension. 2004;44:48-54.
12. Kannel WB. Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med. 1970;72:813-822.
13. Aurigemma GP, Gottdiener JS, Shemanski L, Gardin J, Kitzman D. Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol. 2001;37:1042-1048.
14. Gardin J, McClelland R, Kitzman D, Lima JAC, Bommer W, Klopfenstein HS, Wong ND, Smith V-E, Gottdiener JS. M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study). Am J Cardiol. 2001;87:1051-1057.
15. Drazner MH, Rame JE, Marino EK, Gottdiener JS, Kitzman DW, Gardin JM, Manolio TA, Dries DL, Siscovick DS. Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction with five years: the Cardiovascular Health Study. J Am Coll Cardiol. 2004;43:2207-2215.
16. Kannel WB. Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med. 1983;75(suppl I):4-11.
17. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557-1562.
18. Gottdiener JS, Arnold AM, Aurigemma GP, Polak JF, Tracy RP, Kitzman DW, Gardin JM, Rutledge JE, Boineau RC. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol. 2000;35:1628-1637.
19. Arnold JMO, Yusuf S, Young J, Mathew J, Johnstone D, Avezum A, Lonn E, Pogue J, Bosch J, for the HOPE Investigators. Prevention of heart failure in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation. 2003;107:1284-1290.
20. Aronow WS, Ahn C. Association of electrocardiographic left ventricular hypertrophy with the incidence of new congestive heart failure. J Am Geriatrics Soc. 1998;46:1280-1281.
21. Aronow WS, Ahn C, Kronzon I, Koenigsberg M. Congestive heart failure, coronary events and atherothrombotic brain infarction in elderly blacks and whites with systemic hypertension and with and without echocardiographic and electrocardiographic evidence of left ventricular hypertrophy. Am J Cardiol. 1991;67:295-299.
22. Pope JH, Ruthazer R, Kontos M, Beshansky JR, Griffith JL, Selker HP. The impact of electrocardiographic left ventricular hypertrophy and bundle branch block on the triage and outcome of ED patients with a suspected acute coronary syndrome: a multicenter study. Am J Emerg Med. 2004;22:156-163.
23. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, for the LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint Reduction in Hypertension Study (LIFE): a randomised trial against atenolol. Lancet. 2002;359:995-1003.
24. Dahlöf B, Devereux R, de Faire U, Fyhrquist F, Hedner T, Ibsen H, Julius S, Kjeldsen S, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, for the LIFE Study Group. The Losartan Intervention for Endpoint Reduction (LIFE) in Hypertension Study: rationale, design, and methods. Am J Hypertens. 1997;10:705-713.
25. Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol 1995;25:417-423.
26. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127:757-763.
27. Levy D, Salomon M, D'Agostino RB, Belanger AJ, Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation. 1994;90:1786-1793.
28. Sundström J, Lind L, Ärnlöv J, Zethelius B, Andrén B, Lithell HO. Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men. Circulation. 2001;103:2346-2351.
29. Larsen CT, Dahlin J, Blackburn H, Scharling H, Appleyard M, Sigurd B, Schnohr P. Prevalence and prognosis of electrocardiographic left ventricular hypertrophy, ST segment depression and negative T-wave: the Copenhagen City Heart Study. Eur Heart J. 2002;23:315-324.
30. Palmieri V, Okin PM, Wachtell K, Bella JN, Gerdts E, Boman K, Nieminen MS, Devereux RB. Relationship of electrocardiographic strain pattern to left ventricular diastolic function in hypertensive patients: the LIFE Study. J Am Coll Cardiol. 2005;45:130A. Abstract.
31. Okin PM, Roman MJ, Lee ET, Galloway JM, Howard BV, Devereux RB. Combined echocardiographic left ventricular hypertrophy and electrocardiographic ST depression improve prediction of mortality in American Indians: the Strong Heart Study. Hypertension. 2004;43:769-774.
32. Wachtell K, Palmieri V, Olsen MH, Gerdts E, Papademetriou V, Nieminen MS, Smith G, Dahlöf B, Aurigemma GP, Devereux RB. Change in systolic left ventricular performance after 3 years of antihypertensive treatment: the Losartan Intervention for Endpoint (LIFE) study. Circulation. 2002;106:227-232.